Stock Research for CYTR


Featured Broker: Ally Invest

Get the due diligence for another stock.


CYTR Stock Chart & Research Data

The CYTR chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CYTR chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


CYTR Due diligence Resources & Stock Charts

The CYTR stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View CYTR Detailed Price Forecast - CNN Money CNN View CYTR Detailed Summary - Google Finance
Yahoo View CYTR Detailed Summary - Yahoo! Finance Zacks View CYTR Stock Research & Analysis -

Stock Analysis

TradeIdeas View CYTR Trends & Analysis - Trade-Ideas Barrons View CYTR Major Holders - Barrons
NASDAQ View CYTR Call Transcripts - NASDAQ Seeking View CYTR Breaking News & Analysis - Seeking Alpha
Spotlight View CYTR Annual Report - OTC Report View CYTR OTC Short Report -
TradeKing View CYTR Fundamentals - TradeKing Charts View CYTR SEC Filings - Bar Chart
WSJ View Historical Prices for CYTR - The WSJ Morningstar View Performance/Total Return for CYTR - Morningstar
MarketWatch View the Analyst Estimates for CYTR - MarketWatch CNBC View the Earnings History for CYTR - CNBC
StockMarketWatch View the CYTR Earnings - StockMarketWatch MacroAxis View CYTR Buy or Sell Recommendations - MacroAxis
Bullish View the CYTR Bullish Patterns - American Bulls Short Pains View CYTR Short Pain Metrics -

Social Media Mentions

StockTwits View CYTR Stock Mentions - StockTwits PennyStocks View CYTR Stock Mentions - PennyStockTweets
Twitter View CYTR Stock Mentions - Twitter Invest Hub View CYTR Investment Forum News - Investor Hub
Yahoo View CYTR Stock Mentions - Yahoo! Message Board Seeking Alpha View CYTR Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for CYTR - Insider Cow View Insider Transactions for CYTR - Insider Cow
CNBC View CYTR Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for CYTR - OTC Markets
Yahoo View Insider Transactions for CYTR - Yahoo! Finance NASDAQ View Institutional Holdings for CYTR - NASDAQ

Stock Charts

FinViz View CYTR Stock Insight & Charts - StockCharts View CYTR Investment Charts -
BarChart View CYTR Stock Overview & Charts - BarChart Trading View View CYTR User Generated Charts - Trading View

Latest Financial News for CYTR

CytRx Corporation to Present at the 11th Annual LD Micro Main Event
Posted on Wednesday November 28, 2018

CytRx's wholly owned subsidiary, Centurion BioPharma Corporation, is focused on the development of personalized medicine that will transform solid tumor treatment. This transformational strategy combines a portfolio of novel, anti-cancer drug candidates that employ LADR™ (Linker Activated Drug Release) technology, a discovery engine designed to leverage Centurion's expertise in albumin biology and linker technology for the development of a new class of breakthrough anti-cancer therapies with a unique albumin companion diagnostic (ACDx) that can help identify patients who are most likely to benefit from treatment with the LADR™-derived therapies. This technology allows for the delivery of higher doses of drug directly to the tumor, while avoiding much of the off-target toxicity observed with the parent molecules.  Centurion BioPharma Corporation's website is

Report: Exploring Fundamental Drivers Behind Graphic Packaging Holding, QEP Resources, Inogen, CytRx, Voyager Therapeutics, and Daily Journal Corp. (S.C.) — New Horizons, Emerging Trends, and Upcoming Developments
Posted on Friday November 23, 2018

NEW YORK, Nov. 23, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.

Edited Transcript of CYTR earnings conference call or presentation 2-Nov-18 3:00pm GMT
Posted on Friday November 16, 2018

Q3 2018 CytRx Corp Earnings Call featured highlights include: Ralph Lauren, Estee Lauder, GMS, CytRx and T2 Biosystems
Posted on Monday November 12, 2018 featured highlights include: Ralph Lauren, Estee Lauder, GMS, CytRx and T2 Biosystems

Stock Market & Investing Books

Enter a stock symbol to view the stock details.